Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin + Topotecan in Advanced Cervical Cancer
NCT00826891Phase 2Unknown
- Start
- Feb 2009
- Primary completion
- Jan 2010
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
01
Overview
Phase 2, open-label, single-arm trial of topotecan liposome in Cervical Cancer (CC). Primary endpoint: Response Rate (CR + PR). Status: unknown.
02
Drugs
topotecan liposome
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00826891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00826891.